Harvard Bio sees slight increase in revenue, earnings
Harvard Bioscience said a focus on its global growth strategy and a weaker dollar compared to the British pound and the Euro helped boost revenue slightly, as the life sciences manufacturer brought in $27 million, up 3 percent from $26.1 million in the second quarter of 2013.
Meanwhile, the Holliston-based firm said income from continuing operations was $1 million, or 3 cents per share, up slightly from the same period a year ago.
Harvard Bio said its previous outlook that 2014 would be a “bridge year” to better growth in 2015 stands, as it remains “encouraged” by second-quarter bookings and backlogs.
Bookings for the quarter amounted to $27.4 million, compared with $25.8 million in the second quarter of 2013. Harvard Bio’s backlog at the end of the quarter was $6 million, compared with $5.6 million in the first quarter and $3.8 million in the second quarter of 2013, it said.
WBJ Web Partners
Most Recent
Most Recent
0 Comments